<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02642406</url>
  </required_header>
  <id_info>
    <org_study_id>SEN2015-01</org_study_id>
    <nct_id>NCT02642406</nct_id>
  </id_info>
  <brief_title>Therapy Management With Nab-Paclitaxel in Daily Routine</brief_title>
  <acronym>SERAPHINA</acronym>
  <official_title>Safety, Efficacy and Patient Reported Outcomes of Advanced Breast Cancer Patients: Therapy Management With Nab-Paclitaxel in Daily Routine - SERAPHINA</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Tuebingen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital Tuebingen</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Despite treatment improvements in breast cancer, a large number of patients still progress to
      the metastatic stage. Metastatic breast cancer patients have an extremely unfavorable
      prognosis. Not only efficacy, but also quality of life are in the focus when planning a
      therapy or therapy sequence for metastatic breast cancer patients. Therapy options include
      anti-hormonal Therapy, antibody therapies, other targeted therapies and chemotherapies. One
      of the most effective chemotherapies in the adjuadjuvant and metastatic setting is
      paclitaxel. However drug handling and its side effects can compromise patients quality of
      life and can have an impact on the pharmacokinetics of the drug.

      In metastatic breast cancer patients increasing therapy efficacy and reduction of side effect
      frequency are considered to be advancements of therapy. One of these advancements is the
      development of a cremophor free and albumin bound paclitaxel, nab-Paclitaxel (Abraxane),
      which is thought to have a better efficacy and reduced toxicity profile. Nab-Paclitaxel is
      approved for the treatment of metastatic breast cancer after a failure of first-line therapy
      and when antracyclines are not indicated.

      The SERAPHINA study aims to investigate in the use of nab-Paclitaxel in daily routine and the
      frequency and perception of side effects.

      As a non-interventional study, the SERAPHINA Study will assess the patient characteristics
      and describe the patient cohort, in which nab-Paclitaxel is given. This includes age
      distribution, molecular epidemiological characteristics and characteristics documented by the
      patients themselves.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2015</start_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Epidemiological assessment of progression free survival (PFS) under real life conditions.</measure>
    <time_frame>A patient remains in the study for a maximum of 36 months or until death, whatever occurs first</time_frame>
    <description>PFS defined as the time to the first progression or death after therapy start of nab-Paclitaxel.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Assessment of overall survival ()OS.</measure>
    <time_frame>A patient remains in the study for a maximum of 36 months or until death, whatever occurs first</time_frame>
    <description>OS (overall survival) is defined as the time to death from therapy start of nab-Paclitaxel. Reason for death is taken into consideration as well (BBCS, breast cancer specific survival).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Influence of age on the prognosis and quality of life.</measure>
    <time_frame>A patient remains in the study for a maximum of 36 months or until death, whatever occurs first</time_frame>
    <description>Influence of age on the prognosis will be assessed with the standardized questionnaire FACT-B.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of adverse events, serious adverse events will be reported.</measure>
    <time_frame>A patient remains in the study for a maximum of 36 months or until death, whatever occurs first</time_frame>
    <description>NCI Common Toxicity Criteria Version 4.03</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life Quality of life (FACTB, Version 4)</measure>
    <time_frame>A patient remains in the study for a maximum of 36 months or until death, whatever occurs first</time_frame>
    <description>Patient reported (PRO) quality of life is assessed with the standardized questionnaire FACT-B, Version 4. specific questions,</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life (FACTB-TAXANE, Version 4).</measure>
    <time_frame>A patient remains in the study for a maximum of 36 months or until death, whatever occurs first</time_frame>
    <description>Patient reported (PRO) quality of life is assessed with the standardized questionnaire FACT-B-Taxane, Version 4.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life (NCCN-Distress-Thermometer).</measure>
    <time_frame>A patient remains in the study for a maximum of 36 months or until death, whatever occurs first</time_frame>
    <description>Patient reported (PRO) quality of life is assessed with the standardized questionnaire NCCN-Distress-Thermometer.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life (&quot;Special questions&quot;).</measure>
    <time_frame>A patient remains in the study for a maximum of 36 months or until death, whatever occurs first</time_frame>
    <description>Patient reported (PRO) quality of life is assessed with the questionnaire &quot;Special questions&quot;.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Influence of breast cancer patient characteristics on prognosis.</measure>
    <time_frame>A patient remains in the study for a maximum of 36 months or until death, whatever occurs first</time_frame>
    <description>The patient group is described by patient and tumor characteristics, molecular epidemiological characteristics and a series of questionnaires assessing health and socio-economic status and geriatric assessment status. These parameters that describe the patient cohort will be analyzed with regard to their influence on prognosis, adverse event frequencies, quality of life and therapy decision making.</description>
  </other_outcome>
  <other_outcome>
    <measure>Influence of breast cancer patient characteristics on adverse event frequencies.</measure>
    <time_frame>A patient remains in the study for a maximum of 36 months or until death, whatever occurs first</time_frame>
    <description>The patient group is described by patient and tumor characteristics, molecular epidemiological characteristics and a series of questionnaires assessing health and socio-economic status and geriatric assessment status. These parameters that describe the patient cohort will be analyzed with regard to their influence on prognosis, adverse event frequencies, quality of life and therapy decision making.</description>
  </other_outcome>
  <other_outcome>
    <measure>Influence of breast cancer patient characteristics on quality of life.</measure>
    <time_frame>A patient remains in the study for a maximum of 36 months or until death, whatever occurs first</time_frame>
    <description>The patient group is described by patient and tumor characteristics, molecular epidemiological characteristics and a series of questionnaires assessing health and socio-economic status and geriatric assessment status. These parameters that describe the patient cohort will be analyzed with regard to their influence on prognosis, adverse event frequencies, quality of life and therapy decision making.</description>
  </other_outcome>
  <other_outcome>
    <measure>Influence of breast cancer patient characteristics on therapy decision making.</measure>
    <time_frame>A patient remains in the study for a maximum of 36 months or until death, whatever occurs first</time_frame>
    <description>The patient group is described by patient and tumor characteristics, molecular epidemiological characteristics and a series of questionnaires assessing health and socio-economic status and geriatric assessment status. These parameters that describe the patient cohort will be analyzed with regard to their influence on prognosis, adverse event frequencies, quality of life and therapy decision making.</description>
  </other_outcome>
  <enrollment type="Anticipated">1200</enrollment>
  <condition>Metastatic Breast Cancer</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Blood sampling</intervention_name>
    <description>A blood sample will be taken during a routine blood draw before the application of any nab-Paclitaxel.</description>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood samples
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        1200 patients with locally advanced/metastatic breast cancer for who is curruently or will
        be treated with nab-Paclitaxel according to the approval as stated in the Summary of
        Product Characteristics.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with metastatic breast cancer in which a therapy with nab-paclitaxel was
             indicated by the treating physician

          -  Treatment of nab-Paclitaxel must either have not been started yet, or first
             application of nab-Paclitaxel was not prior to 21 days before study entry

          -  Female patients, age ≥18 years

          -  Invasive breast cancer (irrespective of status of BC, e.g. TNM, receptor status etc.)

          -  Metastatic or locally advanced, inoperable disease proven by clinical measures (i.e.
             standard imaging)

          -  Patients scheduled for nab-Paclitaxel treatment in daily routine before screening

          -  Patients, who are able and willing to sign the informed consent form

        Exclusion Criteria:

          -  Patient is currently enrolled, or will enroll in an interventional clinical study in
             which investigational therapeutic procedures are performed or investigational
             therapies are administered while participating in this study
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Peter Fasching, Prof. Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Frauenklinik des Universitätsfrauenklinikums Erlangen</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Hans Joachim Lück, Prof. Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Gynäkologisch-Onkologische Schwerpunktpraxis am Pelikanplatz</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Diethelm Wallwiener, Prof. Dr.</last_name>
    <role>Study Director</role>
    <affiliation>Universitätsklinikum Tübingen Universitäts-Frauenklinik</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sara Brucker, Prof. Dr.</last_name>
    <role>Study Director</role>
    <affiliation>Universitätsklinikum Tübingen Universitäts-Frauenklinik</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Erik Belleville, PHD</last_name>
    <phone>+49 931 359200</phone>
    <phone_ext>36</phone_ext>
    <email>belleville@clin-sol.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Aalen Brustzentrum</name>
      <address>
        <city>Aalen</city>
        <state>Baden-Württemberg</state>
        <zip>73430</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Freiburg</name>
      <address>
        <city>Freiburg</city>
        <state>Baden-Württemberg</state>
        <zip>79106</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>NCT Heidelberg</name>
      <address>
        <city>Heidelberg</city>
        <state>Baden-Württemberg</state>
        <zip>69120</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Frauenklinik des Städtischen Klinikums</name>
      <address>
        <city>Karlsruhe</city>
        <state>Baden-Württemberg</state>
        <zip>76133</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>St. Vicentius Kliniken gAG</name>
      <address>
        <city>Karlsruhe</city>
        <state>Baden-Württemberg</state>
        <zip>76135</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Ortenau Klinikum Lahr-Ettenheim</name>
      <address>
        <city>Lahr</city>
        <state>Baden-Württemberg</state>
        <zip>77933</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Praxisklinik am Rosengarten</name>
      <address>
        <city>Mannheim</city>
        <state>Baden-Württemberg</state>
        <zip>68165</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Universitätsmedizin Mannheim</name>
      <address>
        <city>Mannheim</city>
        <state>Baden-Württemberg</state>
        <zip>68167</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Paracelsus Krankenhaus Ruit</name>
      <address>
        <city>Ruit</city>
        <state>Baden-Württemberg</state>
        <zip>73760</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Schwerpunktpraxis für Hämatologie und Internistische Onkologie, Gastroenterologie</name>
      <address>
        <city>Singen</city>
        <state>Baden-Württemberg</state>
        <zip>78224</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Brustzentrum</name>
      <address>
        <city>Stuttgart</city>
        <state>Baden-Württemberg</state>
        <zip>70176</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Universitätsfrauenklinik Tübingen</name>
      <address>
        <city>Tübingen</city>
        <state>Baden-Württemberg</state>
        <zip>72076</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>GRN-Klinik Weinheim Abteilung für Gynäkologie und Geburtshilfe</name>
      <address>
        <city>Weinheim</city>
        <state>Baden-Württemberg</state>
        <zip>69469</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Klinikum für Frauenheilkunde und Geburtshilfe Esslingen</name>
      <address>
        <city>Esslingen</city>
        <state>Baden-Württenberg</state>
        <zip>73730</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>MVZ Amberg</name>
      <address>
        <city>Amberg</city>
        <state>Bayern</state>
        <zip>92224</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>phase drei Hämato-Onkologischer Studienkreis am Klinikum Aschaffenburg</name>
      <address>
        <city>Aschaffenburg</city>
        <state>Bayern</state>
        <zip>63739</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Klinikum Augsburg Frauenklinik</name>
      <address>
        <city>Augsburg</city>
        <state>Bayern</state>
        <zip>86156</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Rottal-Inn-Kliniken GmbH</name>
      <address>
        <city>Eggenfelden</city>
        <state>Bayern</state>
        <zip>84307</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Universitätsfrauenklinik Erlangen</name>
      <address>
        <city>Erlangen</city>
        <state>Bayern</state>
        <zip>91012</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>MOPS Elisenhof MOP-Studiengesellschaft</name>
      <address>
        <city>München</city>
        <state>Bayern</state>
        <zip>80335</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Klinikum der Universität München (LMU)</name>
      <address>
        <city>München</city>
        <state>Bayern</state>
        <zip>80337</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Praxisgemeinschaft - Frauenärzte am Stadtpark</name>
      <address>
        <city>Nürnberg</city>
        <state>Bayern</state>
        <zip>90409</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Caritas-Krankenhaus St. Josef</name>
      <address>
        <city>Regensburg</city>
        <state>Bayern</state>
        <zip>93053</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>MVZ Weiden GmbH</name>
      <address>
        <city>Weiden</city>
        <state>Bayern</state>
        <zip>92637</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Praxis Dr. med. Uwe G. Pöhls und Kollegen Fachärzte für Frauenheilkunde und Geburtshilfe</name>
      <address>
        <city>Würzburg</city>
        <state>Bayern</state>
        <zip>97070</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Onkologische Gemeinschaftspraxis</name>
      <address>
        <city>Würzburg</city>
        <state>Bayern</state>
        <zip>97080</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Akad. Lehrkrankenhaus der Charité</name>
      <address>
        <city>Ludwigsfelde</city>
        <state>Brandenburg</state>
        <zip>14947</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Ruppiner Kliniken GmbH</name>
      <address>
        <city>Neuruppin</city>
        <state>Brandenburg</state>
        <zip>16816</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>g.SUND Gynäkologie Kompetenzzentrum</name>
      <address>
        <city>Stralsund</city>
        <state>Brandenburg</state>
        <zip>18435</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Brustzentrum am Elisabeth-KH Leipzig</name>
      <address>
        <city>Leipzig</city>
        <state>Dresden</state>
        <zip>04277</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Klinikum Darmstadt</name>
      <address>
        <city>Darmstadt</city>
        <state>Hessen</state>
        <zip>64283</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Zentrum für Hämatologie und Onkologie Bethanien</name>
      <address>
        <city>Frankfurt</city>
        <state>Hessen</state>
        <zip>60389</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Agaplesion Markus Krankenhaus</name>
      <address>
        <city>Frankfurt</city>
        <state>Hessen</state>
        <zip>60431</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>MVZ Onkologische Kooperation Harz</name>
      <address>
        <city>Goslar</city>
        <state>Hessen</state>
        <zip>38643</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Praxis Ammon/Meyer</name>
      <address>
        <city>Göttingen</city>
        <state>Hessen</state>
        <zip>37073</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Frauenklinik Wetzlar</name>
      <address>
        <city>Wetzlar</city>
        <state>Hessen</state>
        <zip>35578</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Niels-Stensen-Kliniken</name>
      <address>
        <city>Georgsmarienhütte</city>
        <state>Niedersachsen</state>
        <zip>49124</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Gynäkologisch-Onkologische Praxis am Pelikanplatz</name>
      <address>
        <city>Hannover</city>
        <state>Niedersachsen</state>
        <zip>30177</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Klinik f. Frauenheilkunde u. Geburtshilfe</name>
      <address>
        <city>Hannover</city>
        <state>Niedersachsen</state>
        <zip>30625</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Frauenarzt Bewer und Sternberg Gynäkologie</name>
      <address>
        <city>Hannover</city>
        <state>Niedersachsen</state>
        <zip>30659</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Gemeinschaftspraxis f. Hämatologie u. Onkologie</name>
      <address>
        <city>Westerstede</city>
        <state>Niedersachsen</state>
        <zip>26655</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Facharztzentrum am Schloß</name>
      <address>
        <city>Wolfenbüttel</city>
        <state>Niedersachsen</state>
        <zip>38307</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Evangelisches Krankenhaus Bethedsa Mönchengladbach GmbH</name>
      <address>
        <city>Mönchengladbach</city>
        <state>Nordrhein-Westfalens</state>
        <zip>41067</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>MarienHospital Onkologische Praxis</name>
      <address>
        <city>Bonn</city>
        <state>Nordrhein-Westfalen</state>
        <zip>53115</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Marienhospital Bottrop gGmbH</name>
      <address>
        <city>Bottrop</city>
        <state>Nordrhein-Westfalen</state>
        <zip>46236</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Universitätsfrauenklinik Düsseldorf</name>
      <address>
        <city>Düsseldorf</city>
        <state>Nordrhein-Westfalen</state>
        <zip>40225</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Essen</name>
      <address>
        <city>Essen</city>
        <state>Nordrhein-Westfalen</state>
        <zip>45147</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>PIOH Praxis Internistischer Onkologie und Hämatologie</name>
      <address>
        <city>Frechen</city>
        <state>Nordrhein-Westfalen</state>
        <zip>50226</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Dokusan Gesellschaft für medizinische studien mbH &amp; Co .KG</name>
      <address>
        <city>Herne</city>
        <state>Nordrhein-Westfalen</state>
        <zip>44623</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Helios Klinikum Krefeld</name>
      <address>
        <city>Krefeld</city>
        <state>Nordrhein-Westfalen</state>
        <zip>47805</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Gemeinschaftspraxis f. Onkologie und Hämatologie</name>
      <address>
        <city>Köln</city>
        <state>Nordrhein-Westfalen</state>
        <zip>50677</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Kliniken der Stadt Köln g.GmbH</name>
      <address>
        <city>Köln</city>
        <state>Nordrhein-Westfalen</state>
        <zip>51067</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Johannes Wesling Klinikum Minden</name>
      <address>
        <city>Minden</city>
        <state>Nordrhein-Westfalen</state>
        <zip>32429</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Marienkrankenhaus/Brustzentrum</name>
      <address>
        <city>Schwerte</city>
        <state>Nordrhein-Westfalen</state>
        <zip>58239</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Praxisnetzwerk Hämatologie/Onkologie</name>
      <address>
        <city>Troisdorf</city>
        <state>Nordrhein-Westfalen</state>
        <zip>53840</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Onkologische Praxis</name>
      <address>
        <city>Velbert</city>
        <state>Nordrhein-Westfalen</state>
        <zip>42551</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Fachinternistische Gemeinschaftspraxis</name>
      <address>
        <city>Witten</city>
        <state>Nordrhein-Westfalen</state>
        <zip>58452</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hämatologisch-Onkologische Praxis Würselen</name>
      <address>
        <city>Würselen</city>
        <state>Nordrhein-Westfalen</state>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Schwerpunktpraxis für Hämatologie und Onkologie Hansen/Reeb/Pfitzner-Dempfle/Stehle</name>
      <address>
        <city>Kaiserslautern</city>
        <state>Rheinland-Pfalz</state>
        <zip>67655</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Johanniter-Krankenhaus Genthin-Stendal Klinik für Frauenheilkunde und Geburtshilfe</name>
      <address>
        <city>Stendal</city>
        <state>Sachsen-Anhalt</state>
        <zip>39576</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Poliklinik Chemnitz GmbH</name>
      <address>
        <city>Chemnitz</city>
        <state>Sachsen</state>
        <zip>09116</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Onkozentrum Dresden</name>
      <address>
        <city>Dresden</city>
        <state>Sachsen</state>
        <zip>01127</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Onkologische Gemeinschaftspraxis Dresden</name>
      <address>
        <city>Dresden</city>
        <state>Sachsen</state>
        <zip>01307</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Leipzig AöR</name>
      <address>
        <city>Leipzig</city>
        <state>Sachsen</state>
        <zip>04103</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>KKH Torgau, Brustzentrum</name>
      <address>
        <city>Torgau</city>
        <state>Sachsen</state>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Christian-Albrecht-Universitäts Kiel</name>
      <address>
        <city>Kiel</city>
        <state>Schleswig-Holstein</state>
        <zip>24118</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Jena</name>
      <address>
        <city>Jena</city>
        <state>Thüringen</state>
        <zip>07743</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Gynäkologische Gemeinschaftspraxis</name>
      <address>
        <city>Berlin</city>
        <zip>10317</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Charité</name>
      <address>
        <city>Berlin</city>
        <zip>12200</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Hamburg-Eppendorf</name>
      <address>
        <city>Hamburg</city>
        <zip>20246</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Gynäkologische Praxisklinik Harburg</name>
      <address>
        <city>Hamburg</city>
        <zip>21073</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 9, 2015</study_first_submitted>
  <study_first_submitted_qc>December 23, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 30, 2015</study_first_posted>
  <last_update_submitted>October 7, 2016</last_update_submitted>
  <last_update_submitted_qc>October 7, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 10, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Paclitaxel</mesh_term>
    <mesh_term>Albumin-Bound Paclitaxel</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

